English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily Report
| May 22, 2023
Local doctor on balloon sinuplasty: 'This procedure is minimally invasive, safe, painless, fast and effective'
Sam Jackson
| May 10, 2023
Scottsdale doctor on sinusitis: 'If quality of life is not optimized, it's our job as physicians to help patients navigate through those challenges'
Patient Daily
| May 9, 2023
Lilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana
Patient Daily Report
| May 9, 2023
Samet: 'I think that smoking will continue to ebb downwards'
Patient Daily
| May 8, 2023
Top Workplaces Recognizes Avalon in Four Culture Categories
Patient Daily
| May 7, 2023
Weave Welcomes Marcus Bertilson as Chief Strategy & Services Officer
Patient Daily
| May 7, 2023
Weave Wins 3 Cultural Excellence Awards from Top Workplaces USA
Patient Daily
| May 7, 2023
Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
« First
«
1
2
3
4
5
6
7
…
»
Last »